BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $708,000 | +30.9% | 11,605 | -1.4% | 0.02% | +4.5% |
| Q1 2020 | $541,000 | +15.6% | 11,769 | +120.5% | 0.02% | +57.1% |
| Q4 2019 | $468,000 | -40.9% | 5,338 | -38.1% | 0.01% | -48.1% |
| Q3 2019 | $792,000 | -15.7% | 8,626 | +16.8% | 0.03% | -20.6% |
| Q2 2019 | $940,000 | -10.2% | 7,388 | +11.1% | 0.03% | -15.0% |
| Q1 2019 | $1,047,000 | +96.8% | 6,652 | +24.2% | 0.04% | +66.7% |
| Q4 2018 | $532,000 | – | 5,358 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,282,827 | $13,019,794 | 1.84% |
| Birchview Capital, LP | 455,200 | $1,383,808 | 1.18% |
| PFM Health Sciences, LP | 6,040,934 | $18,364,439 | 0.86% |
| Lion Point Capital, LP | 531,256 | $1,615,018 | 0.72% |
| Endurant Capital Management LP | 251,785 | $765,426 | 0.69% |
| Bleichroeder LP | 900,000 | $2,736,000 | 0.67% |
| Connacht Asset Management LP | 31,634 | $96,167 | 0.57% |
| Granahan Investment Management | 5,137,778 | $15,618,845 | 0.56% |
| Frazier Life Sciences Management, L.P. | 1,709,907 | $5,198,117 | 0.34% |
| Contrarius Investment Management Ltd | 1,308,002 | $3,976 | 0.22% |